The FDA recalled the Symbiq pump touchscreen (Hospira Inc.) on Oct. 29. The screen may not properly respond to user selection, may have a delayed response, or register a value other than the one selected by the user, an FDA press release said.
Mental Health and CBD: What's the Latest Info
October 27th 2022Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda Professional to discuss what CBD is used for mental health, where research should go next, and how to ensure that patients are getting effective CBD products.
2 Clarke Drive
Cranbury, NJ 08512